Real-time · AI · Cross-signal
Kerna Laboratories just raised. Here's exactly what to do next.
Who to reach, what to say, and why now — on Kerna Laboratories, plus every funding round, exec hire, and M&A move that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Everyone else gives you a piece
✕Crunchbase & PitchBook list the company — No person, no timing, no opener.
✕ZoomInfo & Apollo sell you a contact — No trigger, no reason to reach out now.
✕LinkedIn Sales Navigator shows you people — No real-time signal, no opener.
✕Clay enriches lists you built — No live signal of its own, no who or when.
✕ChatGPT & gen-AI tools answer on a delay — No live data, no verified contact.
Who to contactWhat to sayWhen to reach outWhy now
Only Fundz delivers all four.
Kerna Laboratories raised an undisclosed amount in seed funding led by Gradient and Humba Ventures to expand operations and development efforts.
PRIVATEJan 14, 2025•over 1 year ago
Round Type
seed
Investors
Jacob KimmelPatrick HsuFocalpoint PartnersPioneer FundTau VenturesHumba VenturesGradient
Description
Kerna Laboratories, an AI biotech startup based in San Francisco, has successfully raised seed funding. This funding will be utilized to enhance their operations and accelerate development endeavors.
Related People
Suggested for you
1 contactFunding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Watching Kerna Laboratories? See every signal — funding, hires, M&A, contracts, sentiment.
Request a demoChoose your plan